The evolution of therapeutic modalities drives the adoption of single-use technologies.
Enhancing the bioavailability of poorly soluble drugs
March 1st 2010Although efforts have been made to improve solubility, many poorly soluble drugs still reach the market. Peter Nielsen discusses new developments in solubilisation technology, which could help those companies seeking to reinvigorate marketed products.
Cost Advantages of Single-Use Technologies
March 1st 2010Single-use technologies can help simplify equipment and facility design, thus bringing cost advantages. But how are these cost advantages realized and what criteria can be used to assess their impact? This article is part of a special issue on Bioprocessing and Sterile Manufacturing.
Nanotechnology: A lifeline for drying pharma pipelines?
March 1st 2010Pharmaceutical Technology Europe spoke with experts about the developments that have shaped the nanotechnology industry today and the benefits that this technology has to offer the pharmaceutical industry, which remain largely untapped.
SOCMA Lends Support for Senate Chemical Security Bill
February 18th 2010The Society for Chemical Manufacturers and Affiliates offered its support for a Senate proposal to extend to 2015 current chemical-security standards, the Chemical Facility Anti-Terrorism Standards, which are set to expire this year.